Skip to main content
NXGL
NASDAQ Industrial Applications And Services

NEXGEL Reports Wider Q1 Loss, Reiterates Going Concern, and Discloses Material Control Weaknesses

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$0.533
Mkt Cap
$6.198M
52W Low
$0.531
52W High
$2.89
Market data snapshot near publication time

summarizeSummary

NEXGEL reported a larger Q1 net loss and increased cash burn, reiterating its going concern warning and disclosing material weaknesses in internal controls, despite recent dilutive financing efforts.


check_boxKey Events

  • Q1 2026 Financial Performance Deteriorates

    Net loss attributable to stockholders widened to $927K for Q1 2026 from $712K in Q1 2025. Revenue decreased by 5.6% to $2.65M, and cash used in operating activities increased to $504K, indicating a growing cash burn.

  • Going Concern Warning Reiterated

    The company reiterated its 'going concern' warning, citing an unrestricted cash balance of $0.2M as of March 31, 2026, and ongoing losses, raising substantial doubt about its ability to continue operations.

  • Material Weaknesses in Internal Controls Disclosed

    The CEO and CFO concluded that disclosure controls and procedures were ineffective as of March 31, 2026, due to material weaknesses, including a lack of proper segregation of duties and 'super user' access issues in financial reporting systems.

  • Highly Dilutive Financing Secured

    NEXGEL secured over $13.5M in new convertible notes and warrants in April and May 2026, including $5.0M for the Celularity acquisition and $8.585M from private placements. These notes have a conversion price of $0.60/share and warrants an exercise price of $0.80/share, representing significant potential dilution.


auto_awesomeAnalysis

NEXGEL reported a wider net loss and increased cash burn in Q1 2026, reinforcing the substantial doubt about its ability to continue as a going concern. This precarious financial position is further complicated by the disclosure of material weaknesses in internal financial controls, indicating significant operational risks. While recent dilutive financing totaling over $13.5 million and the Celularity acquisition provide a critical lifeline, the company's stock is trading near its 52-week low, reflecting investor concern over its financial health and governance issues.

At the time of this filing, NXGL was trading at $0.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.2M. The 52-week trading range was $0.53 to $2.89. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NXGL - Latest Insights

NXGL
May 14, 2026, 5:31 PM EDT
Source: Wiseek News
Importance Score:
8
NXGL
May 14, 2026, 5:29 PM EDT
Filing Type: 10-Q
Importance Score:
9
NXGL
May 12, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
NXGL
Apr 30, 2026, 4:54 PM EDT
Filing Type: 10-K/A
Importance Score:
7
NXGL
Apr 30, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
8
NXGL
Apr 24, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
NXGL
Apr 24, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
NXGL
Apr 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
NXGL
Apr 21, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
NXGL
Apr 21, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
9